Literature DB >> 19277553

Labelling heparan sulphate saccharides with chromophore, fluorescence and mass tags for HPLC and MS separations.

Mark Skidmore1, Abdel Atrih, Ed Yates, Jeremy E Turnbull.   

Abstract

The analysis of heparin/HS saccharides derived from small amounts of tissue or cells is a considerable technical challenge and the development of methods to characterise these carbohydrates has progressed comparatively slowly. A number of procedures have been devised to tag glycans selectively at the reducing end with a group that will enhance the sensitivity of detection and facilitate chromatographic separations. Outlined in this chapter are two useful strategies designed specifically for the analysis of heparin/HS saccharides. The first involves a fluorophore label, Bodipy-FL-hydrazide, which permits highly sensitive (fmol level) detection of saccharides utilising high performance strong anion exchange chromatography. The second facilitates oligosaccharide separation by gel-permeation chromatography and reverse phase high performance ion-pairing chromatography (RP-HPIPC) through the use of a phenylsemicarbazide tag. The latter also serves as an effective mass tag for electrospray mass spectrometry, permitting enhanced analysis of HS saccharides. These methods provide new opportunities for the development of glycomics approaches to study the structure and function of the heparan sulfate family of glycans.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19277553     DOI: 10.1007/978-1-59745-022-5_12

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

Review 1.  Proteoglycomics: recent progress and future challenges.

Authors:  Mellisa Ly; Tatiana N Laremore; Robert J Linhardt
Journal:  OMICS       Date:  2010-08

2.  High-resolution preparative separation of glycosaminoglycan oligosaccharides by polyacrylamide gel electrophoresis.

Authors:  Tatiana N Laremore; Mellisa Ly; Kemal Solakyildirim; Dmitri V Zagorevski; Robert J Linhardt
Journal:  Anal Biochem       Date:  2010-03-06       Impact factor: 3.365

3.  Disaccharide compositional analysis of heparan sulfate and heparin polysaccharides using UV or high-sensitivity fluorescence (BODIPY) detection.

Authors:  Mark A Skidmore; Scott E Guimond; Audrey F Dumax-Vorzet; Edwin A Yates; Jeremy E Turnbull
Journal:  Nat Protoc       Date:  2010-12-02       Impact factor: 13.491

4.  Generating heparan sulfate saccharide libraries for glycomics applications.

Authors:  Andrew K Powell; Yassir A Ahmed; Edwin A Yates; Jeremy E Turnbull
Journal:  Nat Protoc       Date:  2010-04-08       Impact factor: 13.491

5.  Analysis of Glycosaminoglycans Using Mass Spectrometry.

Authors:  Gregory O Staples; Joseph Zaia
Journal:  Curr Proteomics       Date:  2011       Impact factor: 0.837

Review 6.  Hyphenated techniques for the analysis of heparin and heparan sulfate.

Authors:  Bo Yang; Kemal Solakyildirim; Yuqing Chang; Robert J Linhardt
Journal:  Anal Bioanal Chem       Date:  2010-09-19       Impact factor: 4.142

7.  Heparin activates PKR by inducing dimerization.

Authors:  Eric Anderson; Willythssa S Pierre-Louis; C Jason Wong; Jeffrey W Lary; James L Cole
Journal:  J Mol Biol       Date:  2011-09-28       Impact factor: 5.469

8.  Quantitative Disaccharide Profiling of Glycosaminoglycans from Two Different Preparations by PMP and Deuterated PMP Labeling.

Authors:  Meng Zhang; Yi An; Lijuan Zhang
Journal:  Methods Mol Biol       Date:  2022

9.  Glycomics approaches for the bioassay and structural analysis of heparin/heparan sulphates.

Authors:  Tania M Puvirajesinghe; Jeremy E Turnbull
Journal:  Metabolites       Date:  2012-11-28

10.  Differential sulfation remodelling of heparan sulfate by extracellular 6-O-sulfatases regulates fibroblast growth factor-induced boundary formation by glial cells: implications for glial cell transplantation.

Authors:  Jennifer R Higginson; Sophie M Thompson; Alessandra Santos-Silva; Scott E Guimond; Jeremy E Turnbull; Susan C Barnett
Journal:  J Neurosci       Date:  2012-11-07       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.